Cite
HARVARD Citation
Chiodelli, P. et al. (2022). FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer. Cancer letters. pp. 217-224. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chiodelli, P. et al. (2022). FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer. Cancer letters. pp. 217-224. [Online].